- Alternative Medicine
- Mesothelioma Cure
- Mesothelioma Research
- Mesothelioma Doctors
- Mesothelioma Cancer Centers
- Mesothelioma Clinical Trials
Over 30 Billion dollars in trust fund money has been set aside for asbestos victims.
Get a Free copy of Surviving Mesothelioma, Lean on Me, or 100 Questions & Answers About Mesothelioma
Mesolink.org now offeres Free Assistance with VA Claims and other benefits.
Dr. Bruce G Haffty
Contact Information
- 195 Little Albany Street, New Brunswick, New Jersey 08903
- (732) 253-3939
- hafftybg@umdnj.edu
For the first few decades of the twentieth century, physicians did not have much knowledge about mesothelioma, the cancer which is strongly associated with asbestos exposure. It usually takes many years between asbestos exposure and the development of the disease, and since asbestos did not begin to see widespread use until World War I, there were few cases until much later in the century. World War II, and the Cold War era which followed, saw ever increasing amounts of asbestos used, and within a few years there were a corresponding number of mesothelioma cases.
Incidences kept increasing during the 1960s and 1970s, leading many in the health care field to focus on the disease. Thoracic surgeons, who specialize in operations involving the chest area, and oncologists, who specialize in the treatment of cancer, have long been on the front lines of the battle against mesothelioma. Radiation oncologists have likewise made significant contributions to the field, devising new radiation therapy treatments that have fewer side effects and cause less damage to healthy tissue. Pharmaceutical companies continue to research new drugs to combat cancer, and geneticists are studying ways to attack the disease at the most minute levels.
Dr. Bruce G. Haffty has long been at the forefront of the battle against cancer. He is the Chairman of the Department of Radiation Oncology at the University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School/Cancer Institute of New Jersey. He earned his medical degree in 1984 from Yale School of Medicine and remained there for his internship in internal medicine, residency, and chief residency in Therapeutic Radiology. He received certification in Radiation Oncology in 1988 from the American Board of Radiology. Afterwards, he remained at Yale, where he served as a Professor of Therapeutic Radiology, directed the residency program for more than a decade, and was the Vice Chairman and Clinical Director for three years. In 2005, he transferred to the Robert Wood Johnson Medical School/Cancer Institute of New Jersey.
Dr. Haffty has maintained an active clinical practice and is widely recognized for his expertise in breast cancer, as well as cancers of the head and neck. He has headed many research projects and has also served on various committees concerning education and research on radiation oncology.
He is widely published, with more than 200 articles and 30 book chapters to his credit, and is the editor of the Handbook of Radiation Oncology. Over the course of his career, Dr. Haffty has consistently been rated as a top doctor by several organizations and consumer magazines. He has been elected President of the American Board of Radiology as well as President of the American Radium Society.
Dr. Haffty is affiliated with the following hospitals:
- Robert Wood Johnson at Hamilton, 1 Hamilton Health Pl., Trenton, NJ 08690
- William W. Backus Hospital, 326 Washington St., Norwich, CT 06360
- Lawrence & Memorial Hospital, 326 Montauk Ave., New London, CT 06320
- Robert Wood Johnson University Hospital, 1 Robert Wood Johnson Pl., New Brunswick, NJ 08901
- Virtua-Memorial Hospital of Burlington, 175 Madison Ave., Mt. Holly, NJ 08060